Genae reaches into Poland; Catalent inks stem cell manufacturing deal;

> Belgian medical device CRO Genae has expanded into Poland, following moves into Germany and Switzerland. More

> Catalent has signed on with Japan's Center for iPS Cell Research and Application to manufacture monoclonal antibodies for stem cell research. News

> Australia's Clinical Network Services has made its way into the U.K., opening a London office and launching a biometrics service offering. Release

> CRO Worldwide Clinical Trials has inked a deal with BioClinica to use its trial management technology. Item

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.